SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-442102
Filing Date
2013-11-14
Accepted
2013-11-14 16:02:23
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d614499d10q.htm 10-Q 268564
2 EX-31.1 d614499dex311.htm EX-31.1 9145
3 EX-31.2 d614499dex312.htm EX-31.2 9234
4 EX-32.1 d614499dex321.htm EX-32.1 2849
5 EX-32.2 d614499dex322.htm EX-32.2 2939
  Complete submission text file 0001193125-13-442102.txt   2930903

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alse-20130930.xml EX-101.INS 300004
7 XBRL TAXONOMY EXTENSION SCHEMA alse-20130930.xsd EX-101.SCH 38994
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alse-20130930_cal.xml EX-101.CAL 60607
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alse-20130930_def.xml EX-101.DEF 108133
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alse-20130930_lab.xml EX-101.LAB 330361
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alse-20130930_pre.xml EX-101.PRE 214992
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-06533 | Film No.: 131219908
SIC: 2834 Pharmaceutical Preparations